CRO Intel

Dashboard Companies Opportunity Signals Clinical Trials Hiring Intelligence Funding Publications FDA Settings

Company Intelligence

Discover companies with clinical, regulatory and hiring signals
Total Companies

6,643

Company Clinical Trials FDA Signals Hiring Opportunity Confidence Last Seen
Haisco Pharmaceutical Group — — —
75
36% 		7/17/2026 View Intelligence
Haisco Pharmaceutical(australia) — — —
60
36% 		7/17/2026 View Intelligence
Haisco-usa Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Halcygen Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Halda Therapeutics Opco — — —
60
36% 		7/17/2026 View Intelligence
Haleon US Holdings — — —
60
42% 		7/20/2026 View Intelligence
Halia Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Halozyme Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Hameln Pharma — — —
60
36% 		7/17/2026 View Intelligence
Hamlet Pharma — — —
60
36% 		7/17/2026 View Intelligence
Hamsoa Pharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Han Wha Pharma — — —
60
36% 		7/17/2026 View Intelligence
Hanall Biopharma — — —
60
36% 		7/17/2026 View Intelligence
Hangzhou Acea Pharmaceutical Research — — —
60
36% 		7/17/2026 View Intelligence
Hangzhou Adcoris Biopharmacy — — —
60
36% 		7/17/2026 View Intelligence
Hangzhou Caring Cleaning Commodity — — —
60
40% 		7/20/2026 View Intelligence
Hangzhou Cheetah Cell Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Hangzhou Dalton Biosciencesltd 1 trials — —
60
36% 		7/17/2026 View Intelligence
Hangzhou Gensciences Biopharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Hangzhou Glubio Pharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Hangzhou Grand Biologic Pharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Hangzhou Hanx Biopharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Hangzhou Hezheng Pharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Hangzhou Highlightll Pharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Hangzhou Innogate Pharma — — —
60
36% 		7/17/2026 View Intelligence
Hangzhou Jingshen Trading — — —
60
40% 		7/20/2026 View Intelligence
Hangzhou Neoantigen Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Hangzhou Polymed Biopharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Hangzhou Sciwind Biosciences — — —
60
36% 		7/17/2026 View Intelligence
Hangzhou Suxi Biopharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Hangzhou Synrx Therapeutics Biomedical Technology — — —
60
36% 		7/17/2026 View Intelligence
Hangzhou Weben Pharma — — —
60
36% 		7/17/2026 View Intelligence
Hangzhou Yirui Pharmaceutical Technology — — —
60
36% 		7/17/2026 View Intelligence
Hangzhou Zede Pharma-tech — — —
60
36% 		7/17/2026 View Intelligence
Hangzhou Zenshine Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Hangzhou Zhongmei Huadong Pharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Hanhui Pharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Hanmi Pharmaceutical 4 trials — —
75
36% 		7/17/2026 View Intelligence
Hansa Biopharma — — —
60
36% 		7/17/2026 View Intelligence
Hanx Biopharmaceuticals (wuhan) — — —
60
36% 		7/17/2026 View Intelligence
Harbor Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Harman Finochem — — —
60
40% 		7/20/2026 View Intelligence
Harmony Biosciences Management — — —
60
36% 		7/17/2026 View Intelligence
Harpoon Therapeutics A Subsidiary Of Merck & (rahway New Jersey Usa) — — —
60
36% 		7/17/2026 View Intelligence
Harras Pharma Curarina — — —
60
36% 		7/17/2026 View Intelligence
Harris Teeter — — —
60
42% 		7/20/2026 View Intelligence
Harrow Eye — — —
60
42% 		7/20/2026 View Intelligence
Hashmi Herbal Pharma (hhp) Registered Bahawalpur — — —
60
36% 		7/17/2026 View Intelligence
Hasten Biopharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Haupt Pharma Wülfing — — —
60
36% 		7/17/2026 View Intelligence
Showing 2601 - 2650 of 6,643 companies